RECURRENT PLASMA CELL MYELOMA
Clinical trials for RECURRENT PLASMA CELL MYELOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT PLASMA CELL MYELOMA trials appear
Sign up with your email to follow new studies for RECURRENT PLASMA CELL MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for blood cancer patients: study tests safer transplant drug combo
Disease control TerminatedThis study looked at people with blood cancers receiving a stem cell transplant from an unrelated donor. The goal was to find the best drug combination to prevent graft-versus-host disease (GVHD), a serious complication where donor cells attack the patient's body. Researchers com…
Matched conditions: RECURRENT PLASMA CELL MYELOMA
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 09, 2026 12:10 UTC
-
New drug combo aims to keep relapsed myeloma in check after transplant
Disease control TerminatedThis study tested whether a combination of daratumumab and pomalidomide could help control multiple myeloma that has returned after a stem cell transplant. The trial included 13 adults with relapsed disease. The goal was to see if this maintenance therapy could achieve complete r…
Matched conditions: RECURRENT PLASMA CELL MYELOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 14:02 UTC